Marathon Deposit Expanding with High-Grade Gold: 5.75 g/t Au over 16.0 meters, 5.30 g/t Au over 16.0 meters and 6.30 g/t Au over 11.0 meters, Valentine Lake Gold Camp, Newfoundland
Highlights:
Cartier Iron Corporation (CSE: CFE) (“Cartier Iron”) is pleased to announce that it has completed a previously announced non-brokered private placement (the “Private Placement”) of 2,000,000 flow-through units of Cartier Iron at a price of $0.10 per unit (“F-T Units”) for proceeds of $200,000 and 5,000,000 non-flow-through units of Cartier Iron at a price of $0.08 per unit (“Units”) for additional proceeds of $400,000.
Cartier Iron Corporation (CSE: CFE) (“Cartier Iron” or the “Company”), is pleased to announce that the Company has retained New Valley Drilling to complete up to 2,000 metres of diamond drilling to test major targets on its Big Easy Gold property, located approximately 20 km northwest of the town of Clarenville, about 200km northwest of St. John’s, Newfoundland (Figure 1). Big Easy hosts an extensive, but little explored, low sulphidation epithermal gold system that occurs on a prominent boundary between volcanic and sedimentary rocks in the Neoproterozoic Avalon Zone. The Induced Polarization/Resitivity (IP/Res) survey completed in winter 2018 outlined a four kilometre long chargeability anomaly extending from the Big Easy to the ET showings. This anomaly is open along strike to the north and south (see press release May 1, 2018 and Figure 2).
Marathon Gold Corporation (“Marathon” or the “Company”) (TSX: MOZ) is pleased to announce the appointment of Robbert Borst as Chief Operating Officer of the Company effective August 1, 2018. Mr. Borst successfully managed the company’s initial Preliminary Economic Assessment (PEA) for the Valentine Lake Gold Camp which was released on May 17, 2018.
Marathon Gold Corporation (“Marathon” or the “Company”) (TSX:MOZ) is pleased to announce that it has completed its previously announced bought deal prospectus offering of 2,900,000 flow-through common shares in the capital of the Company (“FT Shares”) at a price of $1.05 per FT Share and 5,900,000 common shares in the capital of the Company (“Common Shares”) at a price of $0.85 per Common Share for gross proceeds to the Company of $8,060,000 (the “Offering”). The Offering was conducted by a syndicate of underwriters co-led by Haywood Securities Inc. and RBC Capital Markets and including Canaccord Genuity Corp., Laurentian Bank Securities Inc. and Raymond James Ltd.
FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC: FSDDF) is pleased to announce a binding agreement to purchase 51% of Atlantic Island Cannabis Inc. (to be renamed FSD Atlantic Pharma Inc.) effective July 4, 2018. The agreement involves a strategic investment of $40 million to drive production and sales of legal cannabis in the province of Newfoundland. In the first phase of the project, an indoor high quality 45,000 square foot cannabis production facility will be set up in Freshwater, Carbonear, Newfoundland. This site is expected to bring about economic benefits for the province and to create 200 local, management and construction jobs through a phased expansion approach. Phase two of the project will involve a further expansion of the indoor grow facility to up to approximately 300,000 square feet for the production and processing of legal cannabis.